SKI Market

A+| A| A-|

Indian Indices

Sensex

77,303.63 639.42
( 0.83%)

Global Indices

Nasdaq

49,249.13 -82.20
(-0.17%)

Dow Jones

7,185.72 56.32
(0.79%)

Hang Seng

60,447.00 730.82
(1.22%)

Nikkei 225

10,331.11 -47.97
(-0.46%)

Forex

USD-INR

94.05 0.29
(0.31%)

EUR-INR

109.99 0.01
(0.01%)

GBP-INR

126.84 0.17
(0.14%)

JPY-INR

0.59 0.00
(0.16%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Vilin Bio Med Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

78871

INE0L4V01013

17.34

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

VILINBIO

244.67

55.97

EPS(TTM)

Face Value()

Div & Yield %

0.15

Back

gillette india ltd

UPL reports consolidated net profit of Rs 553.00 crore in the September 2025 quarter

Nov 06,2025

Net profit of UPL reported to Rs 553.00 crore in the quarter ended September 2025 as against net loss of Rs 443.00 crore during the previous quarter ended September 2024. Sales rose 8.38% to Rs 12019.00 crore in the quarter ended September 2025 as against Rs 11090.00 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	12019.00	11090.00	8
OPM %	36.84	30.84	-
PBDT	3894.00	2461.00	58
PBT	3123.00	1764.00	77
NP	553.00	-443.00	LP

77,303.63 639.42 ( 0.83%)

49,249.13 -82.20 (-0.17%)

7,185.72 56.32 (0.79%)

60,447.00 730.82 (1.22%)

10,331.11 -47.97 (-0.46%)

94.05 0.29 (0.31%)

109.99 0.01 (0.01%)

126.84 0.17 (0.14%)

0.59 0.00 (0.16%)